Risk stratification after acute myocardial infarction: is it time to reassess? Implications from the INSPIRE trial

J Nucl Cardiol. 2007 May-Jun;14(3):282-92. doi: 10.1016/j.nuclcard.2007.04.007.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Trials as Topic / statistics & numerical data
  • Humans
  • Myocardial Infarction / diagnostic imaging*
  • Myocardial Infarction / mortality*
  • Myocardial Infarction / therapy
  • Outcome Assessment, Health Care / methods
  • Patient Selection
  • Prognosis
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Risk Assessment / methods*
  • Risk Factors
  • Sensitivity and Specificity
  • Technetium Tc 99m Sestamibi*
  • United States / epidemiology

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi